Hazard ratios for Parkinson's disease associated with dihydropyridine and non-dihydropyridine calcium channel blockers, as compared with beta blockers in hypertension population.

aStratified by baseline disease risk score deciles and adjusted for time varying co-morbidities and medications use (statins, anti-diabetes, anti-platelets, non-steroidal anti-inflammatory drugs, anti-psychotics, ischemic heart disease, heart failure, chronic kidney disease, and chronic obstructive pulmonary disease).eCalculated as quartiles of cumulative defined daily dose (DDD) of the drug class category.ACE, angiotensin converting enzyme; HR, hazard ratio.

(a) 按基线疾病风险评分十分位数分层，并针对时变共病及药物使用（他汀类药物、抗糖尿病药物、抗血小板药物、非甾体抗炎药、抗精神病药物、缺血性心脏病、心力衰竭、慢性肾脏病及慢性阻塞性肺疾病）进行校正。(e) 该指标按药物类别下的累积限定日剂量(defined daily dose, DDD)的四分位数计算。血管紧张素转换酶(angiotensin converting enzyme, ACE)；风险比(hazard ratio, HR)。